Clinical implications of systemic and local immune responses in human angiosarcoma
Abstract Angiosarcomas are a rare subtype of soft-tissue sarcomas which exhibit aggressive clinical phenotypes with limited treatment options and poor outcomes. In this study, we investigated the clinical relevance of the peripheral blood neutrophil-to-lymphocyte ratio (NLR) as a marker of systemic...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d397cd279614abe8c61f05978d8c078 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5d397cd279614abe8c61f05978d8c078 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5d397cd279614abe8c61f05978d8c0782021-12-02T16:06:10ZClinical implications of systemic and local immune responses in human angiosarcoma10.1038/s41698-021-00150-x2397-768Xhttps://doaj.org/article/5d397cd279614abe8c61f05978d8c0782021-02-01T00:00:00Zhttps://doi.org/10.1038/s41698-021-00150-xhttps://doaj.org/toc/2397-768XAbstract Angiosarcomas are a rare subtype of soft-tissue sarcomas which exhibit aggressive clinical phenotypes with limited treatment options and poor outcomes. In this study, we investigated the clinical relevance of the peripheral blood neutrophil-to-lymphocyte ratio (NLR) as a marker of systemic immune response, as well as its correlation with intra-tumoral immune profiles in a subgroup of cases (n = 35) using the NanoString PanCancer IO360 panel and multiplex immunohistochemistry. In the overall cohort (n = 150), angiosarcomas of the head and neck (AS-HN) comprised most cases (58.7%) and median overall survival (OS) was 1.1 year. NLR, classified as high in 78 of 112 (70%) evaluable patients, was independently correlated with worse OS (HR 1.84, 95%CI 1.18–2.87, p = 0.0073). Peripheral blood NLR was positively correlated with intra-tumoral NLR (tNLR) (Spearman’s rho 0.450, p = 0.0067). Visualization of tumor-infiltrating immune cells confirmed that tNLR scores correlated directly with both neutrophil (CD15+ cells, rho 0.398, p = 0.0198) and macrophage (CD68+ cells, rho 0.515, p = 0.0018) cell counts. Interestingly, tNLR correlated positively with oncogenic pathway scores including angiogenesis, matrix remodeling and metastasis, and cytokine and chemokine signaling, as well as myeloid compartment scores (all p < 0.001). In patients with documented response assessment to first-line chemotherapy, these pathway scores were all significantly higher in non-responders (47%) compared to responders. In conclusion, systemic and local immune responses may inform chemotherapy response and clinical outcomes in angiosarcomas.Jason Yongsheng ChanGrace Fangmin TanJoe YeongChee Wee OngDave Yong Xiang NgElizabeth LeeJoanna KohCedric Chuan-Young NgJing Yi LeeWei LiuRu Xin WongChin-Ann Johnny OngMohamad FaridBin Tean TehKhee Chee SooNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Precision Oncology, Vol 5, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Jason Yongsheng Chan Grace Fangmin Tan Joe Yeong Chee Wee Ong Dave Yong Xiang Ng Elizabeth Lee Joanna Koh Cedric Chuan-Young Ng Jing Yi Lee Wei Liu Ru Xin Wong Chin-Ann Johnny Ong Mohamad Farid Bin Tean Teh Khee Chee Soo Clinical implications of systemic and local immune responses in human angiosarcoma |
description |
Abstract Angiosarcomas are a rare subtype of soft-tissue sarcomas which exhibit aggressive clinical phenotypes with limited treatment options and poor outcomes. In this study, we investigated the clinical relevance of the peripheral blood neutrophil-to-lymphocyte ratio (NLR) as a marker of systemic immune response, as well as its correlation with intra-tumoral immune profiles in a subgroup of cases (n = 35) using the NanoString PanCancer IO360 panel and multiplex immunohistochemistry. In the overall cohort (n = 150), angiosarcomas of the head and neck (AS-HN) comprised most cases (58.7%) and median overall survival (OS) was 1.1 year. NLR, classified as high in 78 of 112 (70%) evaluable patients, was independently correlated with worse OS (HR 1.84, 95%CI 1.18–2.87, p = 0.0073). Peripheral blood NLR was positively correlated with intra-tumoral NLR (tNLR) (Spearman’s rho 0.450, p = 0.0067). Visualization of tumor-infiltrating immune cells confirmed that tNLR scores correlated directly with both neutrophil (CD15+ cells, rho 0.398, p = 0.0198) and macrophage (CD68+ cells, rho 0.515, p = 0.0018) cell counts. Interestingly, tNLR correlated positively with oncogenic pathway scores including angiogenesis, matrix remodeling and metastasis, and cytokine and chemokine signaling, as well as myeloid compartment scores (all p < 0.001). In patients with documented response assessment to first-line chemotherapy, these pathway scores were all significantly higher in non-responders (47%) compared to responders. In conclusion, systemic and local immune responses may inform chemotherapy response and clinical outcomes in angiosarcomas. |
format |
article |
author |
Jason Yongsheng Chan Grace Fangmin Tan Joe Yeong Chee Wee Ong Dave Yong Xiang Ng Elizabeth Lee Joanna Koh Cedric Chuan-Young Ng Jing Yi Lee Wei Liu Ru Xin Wong Chin-Ann Johnny Ong Mohamad Farid Bin Tean Teh Khee Chee Soo |
author_facet |
Jason Yongsheng Chan Grace Fangmin Tan Joe Yeong Chee Wee Ong Dave Yong Xiang Ng Elizabeth Lee Joanna Koh Cedric Chuan-Young Ng Jing Yi Lee Wei Liu Ru Xin Wong Chin-Ann Johnny Ong Mohamad Farid Bin Tean Teh Khee Chee Soo |
author_sort |
Jason Yongsheng Chan |
title |
Clinical implications of systemic and local immune responses in human angiosarcoma |
title_short |
Clinical implications of systemic and local immune responses in human angiosarcoma |
title_full |
Clinical implications of systemic and local immune responses in human angiosarcoma |
title_fullStr |
Clinical implications of systemic and local immune responses in human angiosarcoma |
title_full_unstemmed |
Clinical implications of systemic and local immune responses in human angiosarcoma |
title_sort |
clinical implications of systemic and local immune responses in human angiosarcoma |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/5d397cd279614abe8c61f05978d8c078 |
work_keys_str_mv |
AT jasonyongshengchan clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT gracefangmintan clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT joeyeong clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT cheeweeong clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT daveyongxiangng clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT elizabethlee clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT joannakoh clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT cedricchuanyoungng clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT jingyilee clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT weiliu clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT ruxinwong clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT chinannjohnnyong clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT mohamadfarid clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT binteanteh clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma AT kheecheesoo clinicalimplicationsofsystemicandlocalimmuneresponsesinhumanangiosarcoma |
_version_ |
1718385091193864192 |